These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8385810)

  • 1. Platelet and neutrophil function and eicosanoid release in a subject with abetalipoproteinaemia.
    Croft KD; Beilin LJ
    Thromb Res; 1993 Feb; 69(4):333-42. PubMed ID: 8385810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukocyte and platelet function and eicosanoid production in subjects with hypercholesterolaemia.
    Croft KD; Beilin LJ; Vandongen R; Rouse I; Masarei J
    Atherosclerosis; 1990 Aug; 83(2-3):101-9. PubMed ID: 2173612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal platelet functions in a patient with abetalipoproteinemia.
    Surya II; Mommersteeg M; Gorter G; Erkelens DW; Akkerman JW
    Thromb Haemost; 1991 Mar; 65(3):306-11. PubMed ID: 1904656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of lipoproteins on the release of some eicosanoids by stimulated human leukocytes. A possible role in atherogenesis.
    Croft KD; Proudfoot J; Moulton C; Beilin LJ
    Eicosanoids; 1991; 4(2):75-81. PubMed ID: 1654959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma lipid levels and platelet and neutrophil function in patients with vascular disease following fish oil and olive oil supplementation.
    Mori TA; Vandongen R; Mahanian F; Douglas A
    Metabolism; 1992 Oct; 41(10):1059-67. PubMed ID: 1328817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-activating factor and leukotriene biosynthesis in whole blood. A model for the study of transcellular arachidonate metabolism.
    Fradin A; Zirrolli JA; Maclouf J; Vausbinder L; Henson PM; Murphy RC
    J Immunol; 1989 Dec; 143(11):3680-5. PubMed ID: 2555415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelets, neutrophils, and vasoconstriction after arterial injury by angioplasty in pigs: effects of MK-886, a leukotriene biosynthesis inhibitor.
    Provost P; Borgeat P; Merhi Y
    Br J Pharmacol; 1998 Jan; 123(2):251-8. PubMed ID: 9489613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-density lipoproteins supply phospholipid-bound arachidonic acid for platelet eicosanoid production.
    Dobner P; Engelmann B
    Am J Physiol; 1998 Nov; 275(5):E777-84. PubMed ID: 9814996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergism between chemotactic peptide and platelet-activating factor in stimulating thromboxane B2 and leukotriene B4 biosynthesis in human neutrophils.
    Tanizawa H; Tai HH
    Biochem Pharmacol; 1989 Aug; 38(15):2559-63. PubMed ID: 2547385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmin inhibition of platelet function and of arachidonic acid metabolism.
    Schafer AI; Adelman B
    J Clin Invest; 1985 Feb; 75(2):456-61. PubMed ID: 3156149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet function in a case with abetalipoproteinemia.
    Aviram M; Deckelbaum RJ; Brook JG
    Atherosclerosis; 1985 Nov; 57(2-3):313-23. PubMed ID: 4084361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of platelet-activating factor synthesis in human neutrophils and platelets by propionyl-L-carnitine.
    Triggiani M; Oriente A; Golino P; Gentile M; Battaglia C; Brevetti G; Marone G
    Biochem Pharmacol; 1999 Oct; 58(8):1341-8. PubMed ID: 10487538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative changes of hydroxyacid formation during platelet-neutrophil interaction.
    Maderna P; Colli S; Caruso D; Eligini S; Toia A; Galli G; Tremoli E
    J Lab Clin Med; 1993 Mar; 121(3):406-14. PubMed ID: 8383163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet hyperreactivity in hyperlipidaemia with specific reference to platelet lipids and fatty acid composition.
    Chetty N; Naran NH
    Clin Chim Acta; 1992 Dec; 213(1-3):1-13. PubMed ID: 1477981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet activation by polymorphonuclear leukocytes exposed to chemotactic agents.
    Del Maschio A; Evangelista V; Rajtar G; Chen ZM; Cerletti C; De Gaetano G
    Am J Physiol; 1990 Mar; 258(3 Pt 2):H870-9. PubMed ID: 2156456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-activating factor as an intercellular signal in neutrophil-dependent platelet activation.
    Zhou W; Javors MA; Olson MS
    J Immunol; 1992 Sep; 149(5):1763-9. PubMed ID: 1506691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty acid composition of platelets and of plasma lipid esters in relation to platelet function in patients with ischaemic heart disease.
    Boberg M; Vessby B; Croon LB
    Atherosclerosis; 1985 Dec; 58(1-3):49-63. PubMed ID: 2936356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet aggregation is inhibited by a nitric oxide-like factor released from human neutrophils in vitro.
    Faint RW; Mackie IJ; Machin SJ
    Br J Haematol; 1991 Apr; 77(4):539-45. PubMed ID: 1851034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of platelet aggregation by unsaturated fatty acids through interference with a thromboxane-mediated process.
    Sato T; Nakao K; Hashizume T; Fujii T
    Biochim Biophys Acta; 1987 Nov; 931(2):157-64. PubMed ID: 3663714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-leukocyte interaction: activation of rabbit platelets by FMLP-stimulated neutrophils.
    Coëffier E; Joseph D; Prévost MC; Vargaftig BB
    Br J Pharmacol; 1987 Oct; 92(2):393-406. PubMed ID: 3118996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.